Won Jin Ho Selected Research

Bites and Stings (Sting)

1/2021

Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Won Jin Ho Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 12/2010
5	Adenocarcinoma 01/2021 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 10/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2016
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 02/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021
1	Autoimmune Diseases (Autoimmune Disease) 07/2021
1	Margins of Excision 01/2021
1	Bites and Stings (Sting) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Nasopharyngeal Carcinoma 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2019
1	Oropharyngeal Neoplasms 01/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Signet Ring Cell Carcinoma 01/2017
1	Stomach Neoplasms (Stomach Cancer) 10/2016
1	Hypoxia (Hypoxemia) 10/2011
1	Acidosis 12/2010

Drug/Important Bio-Agent (IBA)

4	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2019
4	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2016
2	LigandsIBA 01/2022 - 01/2020
2	NivolumabIBA 01/2022 - 01/2018
2	pembrolizumabIBA 01/2019 - 01/2018
2	MicronutrientsIBA 01/2018 - 02/2015
2	Pharmaceutical PreparationsIBA 10/2011 - 12/2010
1	Granzymes (Granzyme)IBA 01/2022
1	cabozantinibIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Non-Receptor Type 22 Protein Tyrosine PhosphataseIBA 07/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2021
1	HydrogelsIBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	InterferonsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	VaccinesIBA 01/2021
1	IpilimumabIBA 10/2020
1	Cancer VaccinesIBA 10/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2020
1	B7-H1 AntigenIBA 01/2020
1	CytokinesIBA 01/2020
1	ChemokinesIBA 01/2020
1	B-Cell Activating FactorIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	AntibodiesIBA 01/2019
1	PlatinumIBA 01/2018
1	AntioxidantsIBA 02/2015
1	adhesion receptorIBA 10/2011
1	Oxygen (Dioxygen)IBA 10/2011
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2010

Therapy/Procedure

9	Therapeutics 01/2021 - 12/2010
8	Immunotherapy 12/2021 - 01/2018
2	Neoadjuvant Therapy 11/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2017